189295 Agricultural biotechnology after 20 years: What has it achieved?

Tuesday, October 28, 2008: 2:35 PM

Margaret Mellon, PhD , Director, Food & Environment Program, Union of Concerned Scientists, Washington, DC
The first genetically engineered (GE) food crops were planted experimentally in the early 1980's, and GE corn and soybeans have been available commercially since the mid-1990s. Some twenty years after its debut, it is possible to assess whether agricultural technology has lived up to the extravagant promises made by the industry. A critical review of the record reveals that the technology's accomplishments outside the arena of scientific research have been modest, at best. In the United States, engineered corn and soybeans are primarily used as processed food ingredients (e.g., high fructose corn syrup, soybean oil) and feed inputs for meat and dairy production. The two successful GE traits–herbicide tolerance and insect resistance—have reaped benefits for the seed developers and some farmers, but promised reductions in overall pesticide use from adoption of GE crops have not materialized. This presentation will provide a brief history of agricultural biotechnology and compare the promises of agricultural biotechnology in the early 1980's to what has been accomplished. It will examine the industry's successes as well as examples of consumer, environmental, and nutritional benefits that have not emerged. It will also give an overview of public investment (particularly by the U.S. Department of Agriculture) in GE technologies versus organic research, traditional breeding, and other non-GE technologies.

Learning Objectives:
1. Identify the food crops and traits produced commercially through genetic engineering in the last two decades. 2. Evaluate the accomplishments of agricultural biotechnology in providing consumer and environmental benefits through GE food crops. 3. Discuss the extent of public investment in GE technology compared with alternative breeding and farming methods.

Keywords: Food and Nutrition, Research Agenda

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: invited
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.